![logo](/logos/4967.T.webp)
Kobayashi Pharmaceutical Co., Ltd.
TSE:4967.T
5530 (JPY) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 173,455 | 166,258 | 155,252 | 150,514 | 168,052 | 167,479 | 156,761 | 160,067.6 | 137,211 | 128,344 | 127,293 | 121,532 | 131,166 | 130,528 | 129,082 | 125,544 | 228,133 | 257,502 | 247,335 | 216,052 |
Cost of Revenue
| 80,283 | 73,927 | 66,478 | 65,248 | 64,705 | 64,359 | 61,238 | 66,234.501 | 57,518 | 54,718 | 54,193 | 51,732 | 54,635 | 55,889 | 57,193 | 56,864 | 146,945 | 172,783 | 167,721 | 144,256 |
Gross Profit
| 93,172 | 92,331 | 88,774 | 85,266 | 103,347 | 103,120 | 95,523 | 93,833.099 | 79,693 | 73,626 | 73,100 | 69,800 | 76,531 | 74,639 | 71,889 | 68,680 | 81,188 | 84,719 | 79,614 | 71,796 |
Gross Profit Ratio
| 0.537 | 0.555 | 0.572 | 0.566 | 0.615 | 0.616 | 0.609 | 0.586 | 0.581 | 0.574 | 0.574 | 0.574 | 0.583 | 0.572 | 0.557 | 0.547 | 0.356 | 0.329 | 0.322 | 0.332 |
Reseach & Development Expenses
| 9,004 | 8,327 | 7,522 | 7,338 | 7,110 | 7,031 | 7,239 | 5,494.653 | 5,788 | 5,289 | 4,930 | 4,544 | 4,385 | 4,069 | 3,962 | 3,361 | 2,813 | 2,476 | 2,377 | 2,115 |
General & Administrative Expenses
| 5,419 | 5,024 | 5,200 | 5,141 | 5,492 | 5,706 | 5,504 | 3,630.838 | 4,800 | 4,696 | 4,728 | 4,813 | 9,817 | 9,913 | 9,960 | 9,697 | 14,996 | 4,612 | 4,011 | 3,572 |
Selling & Marketing Expenses
| 27,742 | 26,584 | 26,590 | 26,009 | 42,271 | 42,025 | 39,338 | 61,005 | 31,276 | 26,722 | 26,521 | 25,650 | 22,200 | 20,480 | 20,315 | 19,919 | 19,333 | 18,848 | 17,659 | 16,209 |
SG&A
| 57,457 | 31,608 | 31,790 | 31,150 | 47,763 | 47,731 | 44,842 | 64,635.838 | 36,076 | 31,418 | 31,249 | 30,463 | 32,017 | 30,393 | 30,275 | 29,616 | 34,329 | 23,460 | 21,670 | 19,781 |
Other Expenses
| -930 | 25,722 | 23,390 | 20,828 | 22,112 | 22,061 | 976 | -603.998 | -86 | 404 | 515 | 415 | 250 | 158 | 40 | -226 | -3,020 | -3,219 | -2,175 | -1,999 |
Operating Expenses
| 67,391 | 65,657 | 62,702 | 59,316 | 76,985 | 76,823 | 72,589 | 70,734.49 | 61,427 | 55,703 | 54,971 | 52,889 | 50,340 | 49,498 | 48,163 | 46,292 | 54,491 | 45,604 | 43,485 | 39,381 |
Operating Income
| 25,781 | 26,669 | 26,065 | 25,943 | 26,355 | 26,289 | 22,925 | 23,098.609 | 18,260 | 17,917 | 18,122 | 16,903 | 27,026 | 25,552 | 23,750 | 21,882 | 23,353 | 36,166 | 16,879 | 30,960 |
Operating Income Ratio
| 0.149 | 0.16 | 0.168 | 0.172 | 0.157 | 0.157 | 0.146 | 0.144 | 0.133 | 0.14 | 0.142 | 0.139 | 0.206 | 0.196 | 0.184 | 0.174 | 0.102 | 0.14 | 0.068 | 0.143 |
Total Other Income Expenses Net
| 1,778 | 1,281 | 1,571 | 692 | 449 | -985 | -353 | 3,303.992 | 495 | 2,139 | 1,544 | 1,950 | -7,204 | -12,374 | -9,197 | -5,612 | -7,553 | -20,128 | -20,483 | -18,191 |
Income Before Tax
| 27,559 | 27,950 | 27,636 | 26,635 | 26,804 | 25,304 | 22,572 | 26,402.601 | 18,755 | 20,056 | 19,666 | 18,853 | 19,822 | 13,178 | 14,553 | 16,270 | 15,800 | 16,038 | 14,009 | 12,769 |
Income Before Tax Ratio
| 0.159 | 0.168 | 0.178 | 0.177 | 0.159 | 0.151 | 0.144 | 0.165 | 0.137 | 0.156 | 0.154 | 0.155 | 0.151 | 0.101 | 0.113 | 0.13 | 0.069 | 0.062 | 0.057 | 0.059 |
Income Tax Expense
| 7,221 | 7,927 | 7,920 | 7,430 | 7,665 | 7,280 | 6,709 | 7,391.982 | 5,300 | 7,608 | 7,360 | 6,676 | 8,096 | 3,842 | 5,303 | 7,420 | 7,296 | 7,860 | 6,281 | 5,968 |
Net Income
| 20,338 | 20,022 | 19,715 | 19,205 | 19,139 | 18,023 | 15,863 | 19,094.619 | 13,466 | 12,448 | 12,307 | 12,176 | 11,726 | 9,335 | 9,249 | 8,853 | 8,504 | 8,297 | 7,474 | 6,730 |
Net Income Ratio
| 0.117 | 0.12 | 0.127 | 0.128 | 0.114 | 0.108 | 0.101 | 0.119 | 0.098 | 0.097 | 0.097 | 0.1 | 0.089 | 0.072 | 0.072 | 0.071 | 0.037 | 0.032 | 0.03 | 0.031 |
EPS
| 268.16 | 259.61 | 252.35 | 245.7 | 244.07 | 228.04 | 201.31 | 238.82 | 165.55 | 152.72 | 150.28 | 148.68 | 143.18 | 113.98 | 112.93 | 107.93 | 102.8 | 100.38 | 90.06 | 80.85 |
EPS Diluted
| 268.16 | 259.58 | 252.35 | 245.7 | 244.07 | 227.95 | 201.03 | 238.47 | 165.3 | 152.72 | 150.28 | 148.68 | 143.18 | 113.98 | 112.93 | 107.9 | 102.71 | 100.23 | 89.5 | 80.85 |
EBITDA
| 31,838 | 33,819 | 32,982 | 31,666 | 32,143 | 30,912 | 27,867 | 26,598.6 | 21,054 | 21,960 | 21,883 | 21,668 | 30,257 | 29,707 | 28,006 | 26,094 | 27,117 | 38,948 | 37,305 | 33,695 |
EBITDA Ratio
| 0.184 | 0.203 | 0.212 | 0.21 | 0.191 | 0.185 | 0.178 | 0.166 | 0.153 | 0.171 | 0.172 | 0.178 | 0.231 | 0.228 | 0.217 | 0.208 | 0.119 | 0.151 | 0.151 | 0.156 |